Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
NEXT Life Sciences logo — NEXT Life Sciences Introduces Plan A™ A revolutionary, non-h...

NEXT Life Sciences

NEXT Life Sciences Introduces Plan A™ A revolutionary, non-hormonal, reversible procedure that will bring the scientific

Founded 2020 12 employees Seed Total: $1.55M Biotechnology, Life Sciences

General Information

Company Name NEXT Life Sciences
Founded Year 2020
Employees 12
Industries Biotechnology, Life Sciences
Funding Stage Seed
Social

Get notified when NEXT Life Sciences moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About NEXT Life Sciences

NEXT Life Sciences, Inc. has marked its entry as a revolutionary game-changer in the medical device industry. The company has introduced Plan A™, a non-hormonal, reversible procedure that aims to provide a groundbreaking male contraceptive solution. Next Life Sciences is determined to offer a non-hormonal, long-lasting, and reversible alternative, making it an innovative player in the Biotechnology and Life Sciences sectors. Founded in 2020, the company has successfully secured a seed round investment, with Seaside Ventures backing their vision. This strategic investment took place on 18 January 2024, showcasing investor confidence in NEXT Life Sciences' potential to disrupt the industry.

Taxonomy: NEXT Life Sciences, medical device, male contraceptive solution, non-hormonal, reversible procedure, innovation, long lasting, scientific breakthrough

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 1
Investor
18 Jan 2024
Seed Round •••••• 1
Investor
02 Jun 2023
Venture Round •••••• 1
Investor
04 Aug 2022

NEXT Life Sciences Alternatives & Competitors

NEXT Life Sciences vs
Whalen Furniture
Whalen Furniture United States

Quality furniture doesn't just happen; it's a matter of design.

188 employees
Manufacturing
NEXT Life Sciences vs
Gateway Travel Management
Gateway Travel Management United States

Imagine a corporate travel management program... -That truly makes planning easier for your compa...

22 employees
Travel and Tourism
NEXT Life Sciences vs
Spire Property Group
Spire Property Group Vietnam

Let's take a small step together, and guide you to that dream home.

10 employees

FAQ About NEXT Life Sciences

NEXT Life Sciences Introduces Plan A™ A revolutionary, non-hormonal, reversible procedure that will bring the scientific
NEXT Life Sciences was founded in 2020.
NEXT Life Sciences operates in the following industries: Biotechnology, Life Sciences.
NEXT Life Sciences has approximately 12 employees.
NEXT Life Sciences has completed 3 funding rounds, raising a total of $1.55M. The latest funding stage is Seed.
Top alternatives and competitors to NEXT Life Sciences include Whalen Furniture, Gateway Travel Management, Spire Property Group, Strausberg Group, Mission Yoga. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
NEXT Life Sciences and Whalen Furniture are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors NEXT Life Sciences and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy